Profil

ERPICUM Pauline

Département de médecine interne > Service de néphrologie

See author's contact details
Main Referenced Co-authors
Jouret, François  (54)
Detry, Olivier  (34)
Krzesinski, Jean-Marie  (24)
Weekers, Laurent  (18)
Beguin, Yves  (14)
Main Referenced Keywords
kidney transplantation (8); Humans (7); mesenchymal stromal cells (6); Kidney (5); Medicine (all) (5);
Main Referenced Unit & Research Centers
GIGA Cardiovascular Sciences-Cardiology - ULiège (1)
Main Referenced Disciplines
Urology & nephrology (47)
Surgery (22)
Laboratory medicine & medical technology (9)
Hematology (5)
Gastroenterology & hepatology (4)

Publications (total 57)

The most downloaded
2125 downloads
ERPICUM, P., BONVOISIN, C., GROSCH, S., BOVY, C., Pinto Coelho, T., DETRY, O., JOURET, F., WEEKERS, L., & BOUQUEGNEAU, A. (May 2022). Diagnostic et prise en charge thérapeutique du rejet en transplantation rénale. Revue Médicale de Liège, 77 (5-6), 338-344. https://hdl.handle.net/2268/293495

The most cited

124 citations (OpenAlex)

Rowart, P., ERPICUM, P., Detry, O., WEEKERS, L., Grégoire, C., LECHANTEUR, C., BRIQUET, A., Beguin, Y., Krzesinski, J.-M., & Jouret, F. (2015). Mesenchymal Stromal Cell Therapy in Ischemia/Reperfusion Injury. Journal of Immunology Research, 602597. doi:10.1155/2015/602597 https://hdl.handle.net/2268/185820

STOFFELS, A., Jouret, F., ERPICUM, P., & Bouquegneau, A. (September 2024). Comment je traite… une glomérulonéphrite extra-membraneuse. Revue Médicale de Liège, 79 (9), 547 - 553.
Editorial Reviewed verified by ORBi

Navez, M., Pinto Coelho, T., El Karouni, ERPICUM, P., Vandermeulen, M., Lagny, M.-G., Gilbo, N., Thierry, G., Delanaye, P., Cavalier, E., Jouret, F., & Detry, O. (24 May 2024). Development of a Model for Simultaneous Normothermic Perfusion in Porcine Kidney Grafts [Paper presentation]. 61st ERA Congress, Stockholm, Sweden.
Peer reviewed

Navez, M., Pinto Coelho, T., El Karouni Walid, ERPICUM, P., Vandermeulen, M., Lagny, M.-G., CHERAMY-BIEN, J.-P., Gilbo, N., Malisoux, C., GUARIN, C., Thierry, G., Delanaye, P., Cavalier, E., Jouret, F., & Detry, O. (25 April 2024). Development of a model of simultaneous normothermic perfusion of kidney grafts in the pig [Paper presentation]. BVN-SBN Annual Scientific Meeting 2024, Vilvoorde, Belgium.
Peer reviewed

Navez, M., Pinto Coelho, T., El Karouni Walid, ERPICUM, P., Vandermeulen, M., Lagny, M.-G., CHERAMY-BIEN, J.-P., Malisoux, C., GUARIN, C., Thierry, G., Delanaye, P., Cavalier, E., Gilbo, N., Jouret, F., & Detry, O. (15 March 2024). Development of a model of simultaneous normothermic perfusion of kidney grafts in the pig [Paper presentation]. Congrès Société Belge de Transplantation, Bruxelles, Belgium.
Peer reviewed

Cirillo, A., Vandermeulen, M., ERPICUM, P., Pinto Coelho, T., MEURISSE, N., Detry, O., Jouret, F., & De Tullio, P. (09 March 2024). Untargeted NMR-based metabolomics analysis of kidney allograft perfusates identifies a signature of delayed graft function. Metabolomics, 20 (2), 39. doi:10.1007/s11306-024-02106-1
Peer Reviewed verified by ORBi

Bezstarosti, S., ERPICUM, P., Maggipinto, G., Dreyer, G. J., Reinders, M. E. J., Meziyerh, S., Roelen, D. L., De Fijter, J. W., Kers, J., Weekers, L., Beguin, Y., Jouret, F., & Heidt, S. (2024). Allogeneic mesenchymal stromal cell therapy in kidney transplantation: should repeated human leukocyte antigen mismatches be avoided? Frontiers in Genetics, 15. doi:10.3389/fgene.2024.1436194
Peer Reviewed verified by ORBi

Pinto Coelho, T., ERPICUM, P., Navez, M., Zhang, C., Detry, O., & Jouret, F. (December 2023). La mort cérébrale affecte différemment les greffons rénaux par rapport à l’arrêt circulatoire brutal [Paper presentation]. Congrès Annuel Société Francophone de Transplantation, Brest, France.
Peer reviewed

Pinto Coelho, T., Erpicum, P., Navez, M., Chenyu, Z., Detry, O., & Jouret, F. (25 September 2023). LA MORT ENCÉPHALIQUE AFFECTE LES GREFFONS RÉNAUX DE FAÇON DIFFÉRENTE PAR RAPPORT À L’ARRÊT CIRCULATOIRE BRUTAL. Néphrologie et Thérapeutique, 19 (5), 370 - 463. doi:10.1684/ndt.2023.43
Peer Reviewed verified by ORBi

Fank, H.* , Weekers, L.* , Lovinfosse, P.* , Pottel, H., Seidel, L., Jadoul, A., Bouquegneau, A., BONVOISIN, C., Bovy, C., GROSCH, S., Erpicum, P., Hustinx, R., & Jouret, F. (25 August 2023). The uptake of [18F]-fluorodeoxyglucose by the renal allograft correlates with the acute Banff scores of cortex inflammation but not with the 1-year graft outcomes. Frontiers in Transplantation, 2. doi:10.3389/frtra.2023.1236751
Peer reviewed
* These authors have contributed equally to this work.

Cirillo, A., Vandermeulen, M., Erpicum, P., Pinto Coelho, T., MEURISSE, N., Detry, O., Jouret, F., & De Tullio, P. (18 June 2023). Untargeted 1H NMR-based analysis of kidney allograft perfusates identifies a metabolomics signature of delayed graft function [Poster presentation]. Metabolomics Society, Niagara Falls, Canada.

Pinto Coelho, T., Erpicum, P., Navez, M., Zhang, C., POMA, L., Detry, O., & Jouret, F. (June 2023). #3687 KIDNEY TRANSCRIPTOME VARIES BETWEEN DONOR TYPES, WITH A DIFFERENTIAL REPONSE TO ISCHEMIC PRECONDITIONING. Nephrology Dialysis Transplantation, 38 (Supplement 1), 913. doi:10.1093/ndt/gfad063c_3687
Peer Reviewed verified by ORBi

Pinto Coelho, T., Erpicum, P., Navez, M., Zhang, C., POMA, L., Detry, O., & Jouret, F. (25 May 2023). The renal transcriptome differs between donors after circulatory death and donors after brain death, which may influence the efficience of ischemic preconditioning [Paper presentation]. BSN-SBN annual congress, Vilvoorde, Belgium.
Editorial reviewed

Pinto Coelho, T., Erpicum, P., Navez, M., Zhang, C., POMA, L., Detry, O., & Jouret, F. (17 March 2023). The renal transcriptome differs between donors after circulatory death and donors after brain death, which may influence the efficiency of ischemic preconditioning [Paper presentation]. Belgian Transplantation Society Congress 2023, Brussels, Belgium.
Editorial reviewed

Erpicum, P., Pinto Coelho, T., BONVOISIN, C., Bouquegneau, A., GROSCH, S., Navez, M., Vandermeulen, M., Beguin, Y., Detry, O., Jouret, F., & WEEKERS, L. (February 2023). Reprise retardée de fonction du greffon après transplantation rénale : un challenge clinique toujours d’actualité. Revue Médicale de Liège, 78 (2), 107 - 113.
Editorial Reviewed verified by ORBi

Pinto Coelho, T., Erpicum, P., Navez, M., Zhang, C., Detry, O., & Jouret, F. (2023). KIDNEY TRANSCRIPTOME VARIES BETWEEN DONOR TYPES, WITH A DIFFERENTIAL REPONSE TO ISCHEMIC PRECONDITIONING [Paper presentation]. ESOT congress 2023, Athens, Greece.
Peer reviewed

GROSCH, S., ERPICUM, P., BOUQUEGNEAU, A., JOURET, F., & BOVY, C. (May 2022). Le glomérule dans tous ses états. Revue Médicale de Liège, 77 (5-6), 330-337.
Editorial Reviewed verified by ORBi

ERPICUM, P., BONVOISIN, C., GROSCH, S., BOVY, C., Pinto Coelho, T., DETRY, O., JOURET, F., WEEKERS, L., & BOUQUEGNEAU, A. (May 2022). Diagnostic et prise en charge thérapeutique du rejet en transplantation rénale. Revue Médicale de Liège, 77 (5-6), 338-344.
Editorial Reviewed verified by ORBi

GREGOIRE, C., SERVAIS, S., WILLEMS, E., BAUDOUX, E., LECHANTEUR, C., BRIQUET, A., Bettonville, V., DETRY, O., ERPICUM, P., JOURET, F., LOUIS, E., BARON, F., & BEGUIN, Y. (April 2022). Immunothérapie cellulaire au CHU de Liège : avancées, défis et perspectives. Revue Médicale de Liège, 77 (4), 206-211.
Editorial Reviewed verified by ORBi

Erpicum, P., Grosch, S., Bonvoisin, C., Bouquegneau, A., Weekers, L., Radermacher, L., Jouret, F., LEJEUNE, M., Hougrand, O., & Bovy, C. (2022). The Case | An unusual cause of renal vascular thrombi after kidney transplantation. Kidney International, 101 (2), 427-428. doi:10.1016/j.kint.2021.08.008
Peer Reviewed verified by ORBi

VANDERMEULEN, M., Mohamed-Wais, M., ERPICUM, P., DELBOUILLE, M.-H., LECHANTEUR, C., BRIQUET, A., MAGGIPINTO, G., Jouret, F., Beguin, Y., & Detry, O. (2022). Infusion of allogeneic mesenchymal stromal cells after liver transplantation: Five-year follow-up. Liver Transplantation, 28, 636-646. doi:10.1002/lt.26323
Peer reviewed

VANDERMEULEN, M., ERPICUM, P., BLETARD, N., POMA, L., JOURET, F., & DETRY, O. (2022). Effect of the Combination of Everolimus and Mesenchymal Stromal Cells on Regulatory T Cells Levels and in a Liver Transplant Rejection Model in Rats. Frontiers in Immunology, 13, 877953. doi:10.3389/fimmu.2022.877953
Peer Reviewed verified by ORBi

VANDERMEULEN, M., ERPICUM, P., BLETARD, N., POMA, L., Drion, P., JOURET, F., & DETRY, O. (August 2021). Mesenchymal stromal cells combined with everolimus promote Treg expansion but do not synergize in a rat liver transplant rejection model. Transplant International, 34 (S1 OP519), 101.
Peer Reviewed verified by ORBi

Steichen, C., & Erpicum, P. (April 2021). Combining cell-based therapy and normothermic machine perfusion for kidney graft conditioning has gone one step further. American Journal of Transplantation, 21 (4), 1359 - 1360. doi:10.1111/ajt.16260
Peer Reviewed verified by ORBi

BOUQUEGNEAU, A., ERPICUM, P., GROSCH, S., HABRAN, L., HOUGRAND, O., HUART, J., KRZESINSKI, J.-M., Misset, B., Hayette, M.-P., DELVENNE, P., BOVY, C., Kylies, D., huber, T. B., Puelles, V. G., DELANAYE, P., & Jouret, F. (2021). COVID-19-associated nephropathy includes tubular necrosis and capillarycongestion, with evidence of SARS-CoV-2 in the nephron. Kidney International. doi:10.34067/KID.0006992020
Peer Reviewed verified by ORBi

HUART, J., BOUQUEGNEAU, A., Lutteri, L., ERPICUM, P., GROSCH, S., Résimont, G., WIESEN, P., BOVY, C., Krzesinski, J.-M., THYS, M., LAMBERMONT, B., Misset, B., Pottel, H., Mariat, C., CAVALIER, E., Burtey, S., Jouret, F., & DELANAYE, P. (23 January 2021). Proteinuria in COVID‑19: prevalence, characterization and prognostic role. Journal of Nephrology, 34 (3), 355-364. doi:10.1007/s40620-020-00931-w
Peer Reviewed verified by ORBi

BOUQUEGNEAU, A., HUART, J., LUTTERI, L., ERPICUM, P., GROSCH, S., Résimont, G., WIESEN, P., ROUSSEAU, A.-F., BOVY, C., KRZESINSKI, J.-M., THYS, M., LAMBERMONT, B., Misset, B., Pottel, H., DARCIS, G., CAVALIER, E., JOURET, F., & DELANAYE, P. (2021). Survivors of COVID-19 mostly recover from tubular proteinuria and acute kidney injury after hospital discharge. Journal of Nephrology, 34 (4), 967-969. doi:10.1007/s40620-021-01075-1
Peer Reviewed verified by ORBi

VANDERMEULEN, M., ERPICUM, P., WEEKERS, L., BRIQUET, A., LECHANTEUR, C., Detry, O., Beguin, Y., & Jouret, F. (May 2020). Mesenchymal Stromal Cells in Solid Organ Transplantation. Transplantation, 104 (5), 923-936. doi:10.1097/TP.0000000000003077
Peer Reviewed verified by ORBi

Vandermeulen, M., ERPICUM, P., POMA, L., Detry, O., & JOURET, F. (11 March 2020). Impact of mesenchymal stromal cells and/or everolimus on T-reg lymphocyte expansion in rats [Paper presentation]. Annual Meeting, Antwerp, Belgium.

ERPICUM, P., GROSCH, S., BOUQUEGNEAU, A., HUART, J., Résimont, G., BOVY, C., HABRAN, L., Delvenne, P., KRZESINSKI, J.-M., BURTEY, S., DELANAYE, P., & Jouret, F. (2020). Atteintes rénales de la COVID-19. Revue Médicale de Liège. Supplément, 75 (supplément 1), 109-S114.
Peer reviewed

ERPICUM, P., WEEKERS, L., DETRY, O., BONVOISIN, C., DELBOUILLE, M.-H., GREGOIRE, C., BAUDOUX, E., BRIQUET, A., LECHANTEUR, C., MAGGIPINTO, G., SOMJA, J., Pottel, H., Baron, F., Jouret, F., & BEGUIN, Y. (2019). Infusion of third-party mesenchymal stromal cells after kidney transplantation: a phase I-II, open-label, clinical study. Kidney International, 95, 693-707. doi:10.1016/j.kint.2018.08.046
Peer Reviewed verified by ORBi

ERPICUM, P. (2018). Les cellules stromales mésenchymateuses participent au conditionnement ischémique rénal : contribution translationnelle d’une étude clinique de phase I/II en transplantation rénale et d’un modèle murin d’ischémie/reperfusion rénale [Doctoral thesis, Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/315187

ERPICUM, P., Rowart, P., Defraigne, J.-O., Krzesinski, J.-M., & Jouret, F. (2018). What we need to know about lipid-associated injury in case of renal ischemia/reperfusion. American Journal of Physiology. Renal Physiology. doi:10.1152/ajprenal.00322.2018
Peer Reviewed verified by ORBi

ERPICUM, P., Rowart, P., POMA, L., KRZESINSKI, J.-M., DETRY, O., & JOURET, F. (September 2017). Administration of mesenchymal stromal cells before renal ischemia/reperfusion attenuates kidney injury and modulates renal lipid metabolism in rats. Transplant International, 30 (S2), 9 (OS004.
Peer Reviewed verified by ORBi

ERPICUM, P., Rowart, P., POMA, L., Krzesinski, J.-M., DETRY, O., & Jouret, F. (August 2017). Administration of mesenchymal stromal cells before renal ischemia/reperfusion attenuates kidney injury and may modulate renal lipid metabolism in rats. Scientific Reports, 7 (1), 8687. doi:10.1038/s41598-017-08726-z
Peer Reviewed verified by ORBi

Rowart, P., ERPICUM, P., KRZESINSKI, J.-M., Sebbagh, M., & JOURET, F. (2017). Mesenchymal Stromal Cells Accelerate Epithelial Tight Junction Assembly via the AMP-Activated Protein Kinase Pathway, Independently of Liver Kinase B1. Stem Cells International. doi:10.1155/2017/9717353
Peer Reviewed verified by ORBi

WEEKERS, L., ERPICUM, P., DETRY, O., BONVOISIN, C., DELBOUILLE, M.-H., LECHANTEUR, C., BRIQUET, A., BAUDOUX, E., JOURET, F., & BEGUIN, Y. (16 March 2017). Administration of Third-Party Mesenchymal Stromal Cells at the Time of Kidney Transplantation: Interim Safety Analysis at One-Year Follow-Up [Paper presentation]. 24th Annual Meeting, Bruxelles, Belgium.

ERPICUM, P., Rowart, P., POMA, L., KRZESINSKI, J.-M., DETRY, O., & Jouret, F. (16 March 2017). intravenous administration of mesenchymal stream cells modulates renal lipid metabolism in rats [Paper presentation]. 24th Annual Meeting, Bruxelles, Belgium.

Erpicum, P., HANSSEN, O., WEEKERS, L., LOVINFOSSE, P., Meunier, P., TSHIBANDA, L., Krzesinski, J.-M., Hustinx, R., & Jouret, F. (2017). Non-invasive approaches in the diagnosis of acute rejection in kidney transplant recipients, part II: omics analyses of urine and blood samples. NDT Plus, 1-10. doi:10.1093/ckj/sfw077
Peer Reviewed verified by ORBi

HANSSEN, O., Erpicum, P., LOVINFOSSE, P., Meunier, P., WEEKERS, L., TSHIBANDA, L., Krzesinski, J.-M., HUSTINX, R., & Jouret, F. (2017). Non-invasive approaches in the diagnosis of acute rejection in kidney transplant recipients. Part I. In vivo imaging methods. Clinical Kidney Journal, 10 (1), 97-105. doi:10.1093/ckj/sfw062
Peer Reviewed verified by ORBi

Rowart, P., Erpicum, P., Krzesinski, J.-M., Sebbagh, M., & JOURET, F. (18 November 2016). Mesenchymal stromal cells (MSC) accelerate epithelial tight junction assembly via the AMP-activated protein kinase (AMPK) pathway, independently of Liver kinase b1 (Lkb1) [Poster presentation]. American Society of Nephrology | Kidney Week, Chicago, United States.

Rowart, P., Erpicum, P., Krzesinski, J.-M., Sebbagh, M., & JOURET, F. (27 October 2016). Mesenchymal stromal cells (MSC) accelerate epithelial tight junction assembly via the AMP-activated protein kinase (AMPK) pathway, independently of Liver kinase b1 (Lkb1) [Poster presentation]. MiSOT 2016 - The 6th Expert Meeting on Therapeutic MSCs for Immune Modulation, Regensburg, Germany.

Erpicum, P., WEEKERS, L., DETRY, O., BONVOISIN, C., LECHANTEUR, C., BRIQUET, A., BAUDOUX, E., JOURET, F., & BEGUIN, Y. (28 April 2016). Administration of Third-Party Mesenchymal Stromal Cells at the Time of Kidney Transplantation: Interim Safety Analysis at One-Year Follow-Up [Paper presentation]. Annual Meeting of the BVN-SBN, Bruxelles, Belgium.

Rowart, P., Erpicum, P., Defraigne, J.-O., Krzesinski, J.-M., & Jouret, F. (2016). Type 4 dipetidyl-peptidase (DPP-4) expression is decreased at both MRNA and protein levels following renal ischemia/reperfusion in rat and man. Transplant International, 29 (suppl S2), 10-17.
Peer Reviewed verified by ORBi

WEEKERS, L., Erpicum, P., DETRY, O., BONVOISIN, C., BRIQUET, A., LECHANTEUR, C., BAUDOUX, E., JOURET, F., & BEGUIN, Y. (2016). administration of Third-Party Mesenchymal Stromal Cells at the Time of Kidney Transplantation: Interim Safety Analysis at One-Year Follow-Up. Transplant International, 29 (Suppl 2), 13 -p6.
Peer Reviewed verified by ORBi

WEEKERS, L., ERPICUM, P., DETRY, O., JOURET, F., LECHANTEUR, C., DELBOUILLE, M.-H., BRIQUET, A., BAUDOUX, E., & BEGUIN, Y. (November 2015). Third-party mesenchymal stem cell infusion in kidney transplant recipient: 6-month safety interim analysis. Transplant International, 28 (S4), 223-224/BO278.
Peer Reviewed verified by ORBi

ERPICUM, P., Rowart, P., POMA, L., KRZESINSKI, J.-M., DETRY, O., & JOURET, F. (November 2015). Impact of timing administration of mesenchymal stromal cells on serum creatinine following renal ischemia/ reperfusion in rats. Transplant International, 28 (S4), 11/O29.
Peer Reviewed verified by ORBi

Rowart, P., ERPICUM, P., Defraigne, J.-O., Krzesinski, J.-M., & Jouret, F. (13 September 2015). RENAL ISCHEMIA/REPERFUSION DECREASES THE EXPRESSION OF TYPE 4 DIPEPTIDYL-PEPTIDASE (DPP-4) AT BOTH [Paper presentation]. 17th Congress of the European Society for Organ Transplantation, Brussels, Belgium.

Erpicum, P., Rowart, P., POMA, L., Krzesinski, J.-M., DETRY, O., & Jouret, F. (13 September 2015). IMPACT OF TIMING ADMINISTRATION OF MESENCHYMAL STROMAL CELLS ON SERUM CREATININE FOLLOWING RENAL [Paper presentation]. 17th Congress of the European Society for Organ Transplantation, Brussels, Belgium.

Erpicum, P., Rowart, P., POMA, L., Krzesinski, J.-M., DETRY, O., & Jouret, F. (September 2015). Impact du moment d’administration des cellules stromales mésenchymateuses sur la fonction rénale lors d’une ischémie/reperfusion rénale. Néphrologie et Thérapeutique, 11 (5), 257. doi:10.1016/j.nephro.2015.07.002
Peer Reviewed verified by ORBi

WEEKERS, L., ERPICUM, P., DETRY, O., LECHANTEUR, C., BAUDOUX, E., JOURET, F., & BEGUIN, Y. (May 2015). Third-party mesenchymal stem cell infusion in kidney transplant recipient: 6-month safety interim analysis. American Journal of Transplantation, 15 (suppl 3).
Peer Reviewed verified by ORBi

Rowart, P., ERPICUM, P., Defraigne, J.-O., KRZESINSKI, J.-M., & JOURET, F. (24 April 2015). Renal ischemia/reperfusion decreases the expression of DPP-4 [Paper presentation]. BELGIAN SOCIETY OF PHYSIOLOGY AND PHARMACOLOGY, Bruxelles, Belgium.

Rowart, P., ERPICUM, P., Detry, O., WEEKERS, L., Grégoire, C., LECHANTEUR, C., BRIQUET, A., Beguin, Y., Krzesinski, J.-M., & Jouret, F. (2015). Mesenchymal Stromal Cell Therapy in Ischemia/Reperfusion Injury. Journal of Immunology Research, 602597. doi:10.1155/2015/602597
Peer Reviewed verified by ORBi

DETRY, O., JOURET, F., VANDERMEULEN, M., ERPICUM, P., Delens, L., GREGOIRE, C., BRIQUET, A., WEEKERS, L., BAUDOUX, E., LECHANTEUR, C., & BEGUIN, Y. (December 2014). Cellules stromales mésenchymateuses et transplantation d'organes. Revue Médicale de Liège, 69, 53-56.
Peer reviewed

Erpicum, P., DETRY, O., WEEKERS, L., BONVOISIN, C., LECHANTEUR, C., BRIQUET, A., Beguin, Y., Krzesinski, J.-M., & Jouret, F. (2014). Mesenchymal stromal cell therapy in conditions of renal ischaemia/reperfusion. Nephrology Dialysis Transplantation, 29, 1487-1493. doi:10.1093/ndt/gft538
Peer Reviewed verified by ORBi

ERPICUM, P., Krzesinski, J.-M., & Jouret, F. (2014). Place de l'AMP-activated protein kinase dans le preconditionnement ischemique renal. Néphrologie et Thérapeutique. doi:10.1016/j.nephro.2013.10.006
Peer Reviewed verified by ORBi

Hanssen, O., CASTERMANS, E., BOVY, C., WEEKERS, L., ERPICUM, P., DUBOIS, B., Bours, V., Krzesinski, J.-M., & Jouret, F. (2014). Two novel mutations of the CLDN16 gene cause familial hypomagnesaemia with hypercalciuria and nephrocalcinosis. NDT Plus, 7, 282-285. doi:10.1093/ckj/sfu019
Peer Reviewed verified by ORBi

VANDERWECKENE, P., ERPICUM, P., & Krzesinski, J.-M. (29 August 2012). Intérêt de la chronothérapie dans le traitement de l'hypertension artérielle. Revue Médicale Suisse, 8 (351), 1604-1610.
Peer Reviewed verified by ORBi

Contact ORBi